Ajanta Pharma Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,299
4,560
5,589
6,482
6,225
Depreciation, Depletion & Amortization
439
516
444
612
596
Other Funds
887
1,463
1,472
1,264
1,379
Funds from Operations
2,850
3,614
4,562
5,830
5,442
Changes in Working Capital
745
817
1,243
259
2,591
Net Operating Cash Flow
2,105
2,797
3,318
6,089
2,851
Capital Expenditures
1,348
1,036
2,979
2,991
2,627
Sale of Fixed Assets & Businesses
36
-
4
32
1
Purchase/Sale of Investments
658
611
778
882
22
Net Investing Cash Flow
1,971
1,647
2,197
3,841
2,605
Cash Dividends Paid - Total
146
411
1,342
1,287
3
Issuance/Reduction of Debt, Net
57
581
206
717
5
Net Financing Cash Flow
89
992
1,137
2,004
2
Net Change in Cash
45
159
15
244
248
Free Cash Flow
775
1,761
339
3,098
223
Change in Capital Stock
-
-
-
-
-

About Ajanta Pharma

View Profile
Address
Ajanta House
Mumbai Maharashtra 400067
India
Employees -
Website http://www.ajantapharma.com
Updated 09/14/2018
Ajanta Pharma Ltd. operates as a pharmaceutical formulation company, which engages in the manufacturing and marketing of pharmaceutical products. It operates through the following businesses: Branded Generics, Generics, and Institutions. The Branded Generics business offers branded offers products targeting therapeutic segments for treatment of patients.